CTVA vs TGTX · P/E 42, rev $16.91B vs P/E 18, rev $240.3M
Corteva Inc (CTVA) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the CTVA and TGTX stock pages for the full models.
Not investment advice.